The adverse effects of brand-name drug prescribing

被引：7

|

作者：

Flegel, Ken

机构：

来源：

CANADIAN MEDICAL ASSOCIATION JOURNAL | 2012年 / 184卷 / 05期

关键词：

D O I：

10.1503/cmaj.112160

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

收藏

页码：616 / 616

页数：1

相关论文

共 50 条

[1] Industry Payments to Physicians and Prescribing of Brand-name Drugs
Steinbrook, Robert
JAMA INTERNAL MEDICINE, 2016, 176 (08) : 1123 - 1123
[2] A primer on brand-name prescription drug contracting
Kenney, James T.
Keast, Shellie
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2024, 30 (05): : 507 - 513
[3] The relation between brand-name linguistic characteristics and brand-name memory
Lowrey, TM
Shrum, LJ
Dubitsky, TM
JOURNAL OF ADVERTISING, 2003, 32 (03) : 7 - 17
[4] Brand-name buildup
Rutledge, J
FORBES, 1997, 160 (12): : 72 - 72
[5] WHATS IN A BRAND-NAME
ARONSON, JK
BRITISH MEDICAL JOURNAL, 1994, 308 (6937): : 1140 - 1141
[6] Brand-name bespoke
Goldstein, L
FORTUNE, 1998, 138 (08) : 334 - 334
[7] Brand-name savings
Collier, Roger
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2012, 184 (13) : E692 - E692
[8] A brand-name generic
Savage, PR
IEEE SPECTRUM, 2004, 41 (10) : 60 - 61
[9] Brand-name opera
Teachout, T
COMMENTARY, 1998, 106 (05) : 56 - 59
[10] Canadians balk at longer brand-name drug patents
Vogel, Lauren
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2014, 186 (02) : E69 - E69

← 1 2 3 4 5 →